FDA Inspection 675223 — Ipsen BioPharm Ltd
The FDA completed an inspection of Ipsen BioPharm Ltd on Jul 12, 2010 in Wrexham. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 12, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Wrexham (United Kingdom)